Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02655861 · ClinicalTrials.gov registry record
A Multi-center, Prospective Evaluation of Infants and Children With Congenital Ichthyosis
A clinical trial, sponsored by Yale University.
- Terminated
- Registry status
- 21
- Enrollment target
NCT02655861 is a clinical trial that was terminated before completion, run by Yale University. The registered enrollment target is 21 participants.
The verdict
NCT02655861 was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- 21 participants
- Enrollment target
Study Summary
This project will follow babies with ichthyosis over time in order to better understand the natural course of ichthyosis in infants and children and to examine how specific genetic mutations affect clinical characteristics.
Interventions
- OTHER Observation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2015-06 |
| Est. Completion | 2019-06-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02655861
The ClinicalTrials.gov registry entry for NCT02655861 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Observation is the first listed.
NCT02655861 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02655861 about?
NCT02655861 is a clinical study titled "A Multi-center, Prospective Evaluation of Infants and Children With Congenital Ichthyosis". This project will follow babies with ichthyosis over time in order to better understand the natural course of ichthyosis in infants and children and to examine how specific genetic mutations affect clinical characteristics.
What is the current status of trial NCT02655861?
This trial is currently terminated. The enrollment target is 21 participants. The study started on 2015-06. Estimated completion is 2019-06-05.
What interventions are being tested in trial NCT02655861?
The interventions under investigation include: Observation (OTHER).
Who is sponsoring clinical trial NCT02655861?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.